PROVIRON

This brand name is authorized in Brazil, Ecuador, Spain, Israel, Mexico, Turkey, South Africa

Active ingredients

The drug PROVIRON contains one active pharmaceutical ingredient (API):

1 Mesterolone UNII 0SRQ75X9I9 - MESTEROLONE

Read about Mesterolone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PROVIRON Tablet	Web Search	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G03BB01	Mesterolone	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03B Androgens → G03BB 5-androstanon (3) derivatives
Discover more medicines within G03BB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 538912050016213
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 27.590-03-07
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 48881
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 134
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 70645
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699546010042
Country: ZA	Health Products Regulatory Authority	Identifier(s): B/21.7/137